Stay updated on Pembrolizumab in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added, and a prior revision notice (v3.4.1) along with a government funding status notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding lapse notice about NIH operations and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary toggle and updated QC metadata, including 'Last Update Submitted that Met QC Criteria' and a new 'Revision: v3.4.0'. The older label variants ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4') were removed.SummaryDifference0.2%

- Check64 days agoChange DetectedFooter updates include Revision: v3.3.3; removal of the HHS Vulnerability Disclosure link and the older Revision: v3.3.2 reference.SummaryDifference0.1%

- Check85 days agoChange DetectedFooter shows Revision: v3.3.2, replacing Revision: v3.3.1. No changes to study details or other page content.SummaryDifference0.1%

- Check92 days agoChange DetectedPublications section updated: added notes that publications are provided voluntarily and auto-filled from PubMed, and the revision tag is now v3.3.1.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.